Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617

Clinical trial NCT06972628 · RECRUITING

Trial details

NCT number: NCT06972628
Sponsor: Ebrahim S Delpassand
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Castration-Resistant Prostate Cancer Prostate Cancer Patients With Bone Metastasis Prostate Cancer (CRPC)Prostate Cancer Prostate Cancer Metastatic

Start date: 2025-05-23
Primary completion: 2027-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.